Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
9/1/26 Alumis (ALMS) envudeucitinib for Systemic Lupus Erythematosus (SLE) Subscribers Only Subscribers Only Subscribers Only
8/29/26 Tenax Therapeutics (TENX) Simdax for Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension (PH) Subscribers Only Subscribers Only Subscribers Only
8/28/26 Cytokinetics (CYTK) Myqorzo for Cardiomyopathy - Hypertrophic Subscribers Only Subscribers Only Subscribers Only
8/26/26 Agenus (AGEN) AGEN2041 for Colorectal Cancer (CRC) Subscribers Only Subscribers Only Subscribers Only
8/26/26 Agenus (AGEN) balstilimab for Colorectal Cancer (CRC) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
07/31/2025 Subscribers Only Subscribers Only Regulatory - sNDA/sBLA Filing
09/30/2025 Subscribers Only Subscribers Only Trial Announcement - Trial Completion
10/28/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
10/31/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
11/11/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update